LILRB1 Blockade Enhances Bispecific T Cell Engager Antibody–Induced Tumor Cell Killing by Effector CD8+ T Cells

Journal of Immunology - United States
doi 10.4049/jimmunol.1801472
Full Text
Abstract

Available in full text

Date
Authors
Publisher

The American Association of Immunologists